Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |